




Session One: C-Peptide, T1D and Unmet Need
A Talk by Chantal Mathieu , Kuanysh Kabytaev , Julie Heverly , Hailey Davenport and Teresa Quattrin
Register To Watch This Content
This Talk has ended, but you can still watch the replay! Register now to get access.
About this Talk
While the treatment for T1D has seen many advancements in recent years, there nonetheless remains significant unmet need that could be addressed by disease-modifying therapies. This session will examine this unmet need and the current state of therapy in the setting of newly diagnosed T1D. In addition, this session will provide a baseline background on C-peptide and its characteristics as a biomarker.
- Topic One: Current State of New-Onset T1D Therapy
- Topic Two: Unmet Need in New-Onset T1D (What needs to get better and what isn’t being addressed?)
- Topic Three: C-Peptide Background (Focused on its technical characteristics, utility, and limitations as a biomarker)
- Panel Discussion: Are Things Good Enough as They Are?